Pain in Terminally Ill Patients
- 1 January 2003
- journal article
- Published by Springer Nature in CNS Drugs
- Vol. 17 (9) , 621-631
- https://doi.org/10.2165/00023210-200317090-00002
Abstract
Successful pharmacological treatment of pain in terminally ill patients is possible most of the time. It requires a determination of the type of pain syndrome (i.e. nociceptive, neuropathic or mixed). Complete pain assessment also requires an understanding of other dimensions of suffering that a patient may be experiencing on psychological, social and spiritual/existential levels.Keywords
This publication has 13 references indexed in Scilit:
- Venlafaxine in neuropathic pain following treatment of breast cancerEuropean journal of pain, 2002
- The analgesic tramadol has minimal effect on gastrointestinal motor functionBritish Journal of Clinical Pharmacology, 1997
- Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicatorsPain, 1996
- Intrathecal Amitriptyline Acts as an N-Methyl-D-Aspartate Receptor Antagonist in the Presence of Inflammatory Hyperalgesia in RatsAnesthesiology, 1995
- Hydromorphone metabolite accumulation in renal failureJournal of Pain and Symptom Management, 1995
- Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trialEuropean Journal Of Cancer, 1994
- Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgiaNeurology, 1991
- The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathyPain, 1990
- Intravenous lidocaine infusion — a new treatment of chronic painful diabetic neuropathy?Pain, 1987
- Clonazepam in Facial Neuralgia and Cluster HeadacheEuropean Neurology, 1975